Adverum Biotechnologies Inc (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 0 | 0 | 1,000 | 0 | 0 |
| Gross Profit | N/A | N/A | 1,000 | N/A | N/A |
| Operating Expenses | 48,221 | 59,857 | 30,221 | 20,882 | 29,199 |
| Operating Income | -48,221 | -59,857 | -29,221 | -20,882 | -29,199 |
| Other Income | 1,202 | 1,687 | 2,087 | 2,406 | 2,052 |
| Pre-tax Income | -47,019 | -58,170 | -27,134 | -18,476 | -27,147 |
| Net Income Continuous | -47,019 | -58,170 | -27,134 | -18,476 | -27,147 |
| Net Income | $-47,019 | $-58,170 | $-27,134 | $-18,476 | $-27,147 |
| EPS Basic Total Ops | -2.25 | -2.78 | -1.30 | -0.89 | -1.65 |
| EPS Basic Continuous Ops | -2.25 | -2.79 | -1.30 | -0.89 | -1.65 |
| EPS Diluted Total Ops | -2.25 | -2.78 | -1.30 | -0.89 | -1.65 |
| EPS Diluted Continuous Ops | -2.25 | -2.79 | -1.30 | -0.89 | -1.65 |
| EPS Diluted Before Non-Recurring Items | -2.25 | -1.96 | -1.30 | -0.89 | -1.50 |
| EBITDA(a) | $-47,974 | $-59,661 | $-28,849 | $-20,368 | $-28,535 |